Metaphit (1-[1-(3-isothiocyanatophenyl)-cyclohexylipiperidine), a derivative of the psychotomimetic drug phencyclidine (PCP), is postulated to bind irreversibly to PCP receptors. We examined here the electrophysiological interactions ofmetaphit with PCP in rat cerebellar cortex, since a specific effect of PCP on cerebellar neuronal circuitry has been shown. Metaphit, applied locally to Purkinje neurons by micropressure ejection through multibarreled micropipettes, has a reversible depressant action lasting for 5-20 min. Following this, PCP-induced inhibition is blocked with no recovery despite repeated applications ofPCP for over an hour. This blockade was not seen unless the dose of metaphit was sufficient to transiently depress Purkinje neuron discharge. Metaphit does not antagonize inhibitory effects of locally applied norepinephrine or r-aminobutyric acid. This electrophysiological data suggests that metaphit is an irreversible antagonist of PCP in the cerebellum.The violently aggressive behavior and long-lasting psychosis induced by PCP [1-(1-phenylcyclohexyl)piperidine] abuse has caused societal concern in many areas of the United States. The psychosis induced by PCP is similar to that displayed in schizophrenia, and it has been noted that it might serve as a useful drug model for schizophrenia (1). No specific treatment for PCP psychosis is available (2). For these reasons and many others, the mode of action of PCP in the brain has been investigated by many workers (3).Extensive evidence has been obtained for the presence of specific receptors in the brain for PCP and similar compounds. Binding sites for which compounds similar to PCP have high affinity have been noted to be most prevalent in the striatum, cortex, and hippocampal regions of the brain (4-8).There is a high statistical correlation between the binding affinity of these compounds in vitro and their in vivo activity. The stereospecificity of the interaction of compounds similar to PCP with the PCP receptors in vitro and in vivo has also been noted (9)(10)(11). Further, an endogenous ligand for the PCP receptor has been reported (12). Evidence has been obtained that multiple receptors may exist for compounds similar to PCP (4,13,14). Biochemical studies with a new site-directed acylating agent for the PCP receptors have provided further evidence for the existence of multiple receptors for compounds similar to PCP. This affinity ligand, metaphit (1-[1-(3-isothiocyanatophenyl)cyclohexyl]piperidine), irreversibly inactivated only about 50% of the receptors in the striatum and hippocampus, the two brain areas that were investigated (15). The effect of metaphit on the binding of PCP in striatum has been correlated with a diminished behavioral efficacy of PCP (16).Our previous findings strongly suggested that stereospecific PCP-induced depressions of cerebellar Purkinje neurons are mediated by catecholamine pathways (17). The stereospecific effect of the PCP derivative 1-(1-phenylcyclohexyl)-3-methyl-piperidine on cerebellar Purkinje neurons ...